Ekso Bionics Holdings, Inc. Annual report pursuant to Section 13 and 15(d)

Quarterly Data (Unaudited)

12 Months Ended

Dec. 31, 2015

18. Quarterly Data (Unaudited)

The following is a summary of quarterly results of operation for the years ended December 31, 2015 and 2014:

	Quarter Ended
	March 31		June 30		September 30		December 31
2015
Revenue	$	1,689	$	2,114	$	2,915	$	1,943
Gross profit		403		502		468		(194)
Net loss		(4,115)		(5,645)		(5,185)		(4,645)
Net loss attributable to common shareholders		(4,115)		(5,645)		(5,185)		(9,300)

Basic and diluted net loss per share		(0.04)		(0.06)		(0.05)		(0.09)

2014
Revenue	$	1,062	$	1,197	$	1,588	$	1,480
Gross profit		480		45		480		554
Net income (loss)		(81,766)		56,128		12,024		(20,155)

Basic net income (loss) per share		(1.22)		0.72		0.15		(0.23)
Diluted net income (loss) per share		(1.22)		(0.05)		(0.04)		(0.23)